Stock Scorecard



Stock Summary for Rezolute Inc (RZLT) - $2.12 as of 3/27/2024 6:00:07 AM EST

Total Score

12 out of 29

Currently on the following lists
None
Tim's Recommendation
Avoid

Growth List Algorithm Criteria for RZLT

Positive earnings growth
P/E ratio less than Industry P/E Ratio
P/E ratio less than Sector P/E Ratio
P/E ratio that is half the growth rate (or less)
Positive net cash position the past year and most recent quarter
Equity to debt ratio greater than 0.75 for past year and most recent quarter
Positive net income past year and 12 trailing months
Free cash flow ratio greater than 0 and less than 10

Small Cap List Algorithm Criteria for RZLT

Revenue growing by at least 20% average per year over the last 5 years
Market Capitalization under 2 billion
Price to Sales (P/S) ratio 12 trailing months less than Industry P/S ratio twelve trailing months
Price to Sales (P/S) ratio 12 trailing months less than Sector P/S ratio twelve trailing months
Net Income past year > Net Income prior year OR Net Income 12 trailing months > Net Income prior year OR Net Income 12 trailing months > Net Income past year

Dividend List Algorithm Criteria for RZLT

Declared an ex-dividend date
Forward annual dividend rate greater than 2
Positive net cash position the past year and most recent quarter
Equity to debt ratio greater than 0.75 for past year and most recent quarter
Current ratio most recent quarter greater than 2

Bonus Criteria for RZLT

P/E ratio less than five-year Average P/E ratio
Last Price to 52 Week Low Ratio Less Than 1
Total Cash Per Share > Last Day Price
P/S Ratio < 1
P/B Ratio < 1

Latest News for for RZLT

$17M Bet On This Healthcare Stock? Check Out These 4 Penny Stocks Insiders Are Aggressively Buying - Bespoke Extracts ( OTC:BSPK ) , CPS Technologies ( NASDAQ:CPSH ) 3/20/2024 10:58:00 AM
$1.5M Bet On This Penny Stock? Check Out These 4 Stocks Under $5 Insiders Are Aggressively Buying - Advantage Solutions ( NASDAQ:ADV ) , Marpai ( NASDAQ:MRAI ) 3/11/2024 6:46:00 PM
Rezolute Reports Validation of the Potential Use of RZ358 for Treatment of Non-Islet Cell Tumor Hypoglycemia ( NICTH ) 3/6/2024 12:30:00 PM
Lumen Technologies And 3 Other Stocks Under $3 Insiders Are Buying - Brightcove ( NASDAQ:BCOV ) , Cyanotech ( OTC:CYAN ) 2/28/2024 12:21:00 PM
Charles & Colvard And 3 Other Stocks Under $2 Insiders Are Buying - Charles & Colvard ( NASDAQ:CTHR ) , Cosmos Health ( NASDAQ:COSM ) 2/22/2024 1:51:00 PM
Rezolute And 3 Other Penny Stocks Insiders Are Buying - Citizens ( NYSE:CIA ) , Beasley Broadcast Group ( NASDAQ:BBGI ) 2/21/2024 1:26:00 PM
Rezolute Receives Innovation Passport Designation from the U.K. Innovative Licensing and Access Pathway Steering Group for RZ358 in the Treatment of Hypoglycemia Due to Congenital Hyperinsulinism 1/23/2024 1:00:00 PM
Why Aclarion Shares Are Trading Higher By Around 53%; Here Are 20 Stocks Moving Premarket - argenx ( NASDAQ:ARGX ) , Aclarion ( NASDAQ:ACON ) 12/20/2023 1:30:00 PM
Rezolute Completes Enrollment of its Phase 2 Study in Diabetic Macular Edema ( "DME" ) 12/13/2023 1:00:00 PM
Rezolute to Participate in BTIG's 3rd Annual Ophthalmology Day - Rezolute ( NASDAQ:RZLT ) 11/17/2023 1:00:00 PM

Financial Details for RZLT

Company Overview

Ticker RZLT
Company Name Rezolute Inc
Country USA
Description Rezolute, Inc., a clinical-stage biopharmaceutical company, develops rare and metabolic disease therapies in the United States. The company is headquartered in Redwood City, California.
Sector Name LIFE SCIENCES
Industry Name PHARMACEUTICAL PREPARATIONS
Most Recent Quarter 12/31/2023
Next Earnings Date 5/9/2024

Stock Price History

Last Day Price 2.12
Last Day Price Updated 3/27/2024 6:00:07 AM EST
Last Day Volume 249,146
Average Daily Volume 397,212
52-Week High 2.40
52-Week Low 0.72
Last Price to 52 Week Low 194.44%

Valuation Measures

Trailing PE N/A
Industry PE 100.07
Sector PE 60.76
5-Year Average PE -2.30
Free Cash Flow Ratio 0.91
Industry Free Cash Flow Ratio 12.70
Sector Free Cash Flow Ratio 31.04
Current Ratio Most Recent Quarter 12.00
Total Cash Per Share 2.34
Book Value Per Share Most Recent Quarter 2.32
Price to Book Ratio 0.82
Industry Price to Book Ratio 5.57
Sector Price to Book Ratio 21.66
Price to Sales Ratio Twelve Trailing Months 0.00
Industry Price to Sales Ratio Twelve Trailing Months 13.94
Sector Price to Sales Ratio Twelve Trailing Months 8.77

Share Statistics

Total Shares Outstanding 39,625,300
Market Capitalization 84,005,636
Institutional Ownership N/A

Dividends

Ex-Dividend Date N/A
Last Dividend Amount 0.00
Current Dividend Amount 0.00
Dividend Aristocrat? False
Trailing Annual Dividend Rate 0.00
Trailing Annual Dividend Yield 0.00%
Forward Annual Dividend Rate 0.00
Forward Annual Dividend Yield 0.00%
5-Year Dividend Payments Count 0
3-Year Average Dividend Yield 0.00%
5-Year Average Dividend Yield 0.00%
1-Year Dividend Growth Rate Percentage 0.00%
3-Year Dividend Growth Rate Percentage 0.00%
5-Year Dividend Growth Rate Percentage 0.00%
All-Time Dividend Growth Rate Percentage 0.00%
Dividend Payout Ratio N/A

Income Statement

Quarterly Earnings Growth YOY 0.00%
Annual Earnings Growth -26.13%
Reported EPS 12 Trailing Months -1.10
Reported EPS Past Year -0.55
Reported EPS Prior Year -1.00
Net Income Twelve Trailing Months -56,809,000
Net Income Past Year -51,787,000
Net Income Prior Year -41,060,000
Quarterly Revenue Growth YOY 0.00%
5-Year Revenue Growth 0.00%

Balance Sheet

Total Cash Most Recent Quarter 92,604,000
Total Cash Past Year 101,860,000
Total Cash Prior Year 150,410,000
Net Cash Position Most Recent Quarter 92,604,000
Net Cash Position Past Year 101,860,000
Long Term Debt Past Year 0
Long Term Debt Prior Year 407,000
Total Debt Most Recent Quarter 0
Equity to Debt Ratio Past Year 1.00
Equity to Debt Ratio Most Recent Quarter 1.00
Total Stockholder Equity Past Year 116,172,000
Total Stockholder Equity Prior Year 149,471,000
Total Stockholder Equity Most Recent Quarter 91,728,000

Options

Put/Call Ratio 0.00
Has Options False
Liquidity Rating None

Technical Analysis

Yahoo Finance Chart Yahoo Finance Chart
MACD 0.13
MACD Signal 0.15
20-Day Bollinger Lower Band 0.35
20-Day Bollinger Middle Band 1.24
20-Day Bollinger Upper Band 2.13
Beta 1.22
RSI 60.58
50-Day SMA 1.50
200-Day SMA 6.37

System

Modified 3/27/2024 6:00:53 AM EST